UBS Maintains Neutral on Calumet, Raises Price Target to $47
Calumet, Inc.
Calumet, Inc. CLMT | 0.00 |
UBS analyst Manav Gupta maintains Calumet (NASDAQ:
CLMT) with a Neutral and raises the price target from $26 to $47.
UBS Maintains Neutral on Calumet, Raises Price Target to $47
Calumet, Inc. CLMT | 0.00 |